Open-Label Phase 1/2 Study of NEO-811 in Subjects With Locally Advanced or Metastatic Non-Resectable Clear Cell Renal Cell Carcinoma

Clinical trial NCT07300241 · RECRUITING

Trial details

NCT number: NCT07300241
Sponsor: Neomorph, Inc
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Clear Cell Renal Cell Carcinoma Renal Cell Carcinoma RCC Clear Cell Renal Cell Carcinoma Metastatic ccRCC VHL-Associated Clear Cell Renal Cell Carcinoma VHL-Associated Renal Cell Carcinoma Kidney Cancer Metastatic Kidney Cancers

Start date: 2025-12-19
Primary completion: 2027-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.